Applied Genetic Technologies' IPO

Applied Genetic Technologies raised a round of funding on March 27, 2014. Investors include Public.

Applied Genetic Technologies Corporation is focused on developing gene therapy products derived from adeno-associated virus (AAV) for the treatment of inherited and acquired diseases. AGTC's lead prod…

Articles about Applied Genetic Technologies' IPO: